|
1
|
Dolecek TA, Pro JM, Stroup NE and Kruchko
C: CBTRUS statistical report: Primary brain and central nervous
system tumors diagnosed in the United States in 2005–2009. Neuro
Oncol. 14:(Suppl 5). v1–v49. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stupp R, Mason WP, van den Bent MJ, et al:
European Organisation for Research and Treatment of Cancer Brain
Tumor and Radiotherapy Groups; National Cancer Institute of Canada
Clinical Trials Group: Radiotherapy plus concomitant and adjuvant
temozolomide for glioblastoma. N Engl J Med. 352:987–996. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brandes AA, Franceschi E, Toson A,
Benevento F, Scopece L, Mazzocchi V, Bacci A, Agati R, Calbucci F
and Ermani M: Temozolomide concomitant and adjuvant to radiotherapy
in elderly patients with glioblastoma: Correlation with MGMT
promoter methylation status. Cancer. 115:3512–3518. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Arvold ND and Reardon DA: Treatment
options and outcomes for glioblastoma in the elderly patient. Clin
Interv Aging. 9:357–367. 2014.PubMed/NCBI
|
|
5
|
Combs SE, Wagner J, Bischof M, Welzel T,
Wagner F, Debus J and Schulz-Ertner D: Postoperative treatment of
primary glioblastoma multiforme with radiation and concomitant
temozolomide in elderly patients. Int J Radiat Oncol Biol Phys.
70:987–992. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Minniti G and Enrici RM: Radiation therapy
for older adults with glioblastoma: Radical treatment, palliative
treatment, or no treatment at all? J Neurooncol. 120:225–233. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Minniti G, Lanzetta G, Scaringi C,
Caporello P, Salvati M, Arcella A, De Sanctis V, Giangaspero F and
Enrici RM: Phase II study of short-course radiotherapy plus
concomitant and adjuvant temozolomide in elderly patients with
glioblastoma. Int J Radiat Oncol Biol Phys. 83:93–99. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cao JQ, Fisher BJ, Bauman GS, Megyesi JF,
Watling CJ and Macdonald DR: Hypofractionated radiotherapy with or
without concurrent temozolomide in elderly patients with
glioblastoma multiforme: A review of ten-year single institutional
experience. J Neurooncol. 107:395–405. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
PERRY JR, O'Callaghan CJ, Ding K, et al: A
phase III randomized controlled trial of short-course radiotherapy
with or without concomitant and adjuvant temozolomide in elderly
patients with glioblastoma (NCIC CTG CE.6, EORTC 26062–22061, TROG
08.02, NCT 00482677). Neuro O ncol. 16:(Suppl 3). iii462014.
View Article : Google Scholar
|
|
10
|
Wick W, Platten M, Meisner C, et al:
NOA-08 Study Group of Neuro-oncology Working Group (NOA) of German
Cancer Society: Temozolomide chemotherapy alone versus radiotherapy
alone for malignant astrocytoma in the elderly: The NOA-08
randomised, phase 3 trial. Lancet Oncol. 13:707–715. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Malmström A, Grønberg BH, Marosi C, et al:
Nordic Clinical Brain Tumour Study Group (NCBTSG): Temozolomide
versus standard 6-week radiotherapy versus hypofractionated
radiotherapy in patients older than 60 years with glioblastoma: The
Nordic randomised, phase 3 trial. Lancet Oncol. 13:916–926. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gállego Pérez-Larraya J, Ducray F, Chinot
O, et al: Temozolomide in elderly patients with newly diagnosed
glioblastoma and poor performance status: An ANOCEF phase II trial.
J Clin Oncol. 29:3050–3055. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yin AA, Cai S, Dong Y, Zhang LH, Liu BL,
Cheng JX and Zhang X: A meta-analysis of temozolomide versus
radiotherapy in elderly glioblastoma patients. J Neurooncol.
116:315–324. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Iwamoto FM, Reiner AS, Panageas KS, Elkin
EB and Abrey LE: Patterns of care in elderly glioblastoma patients.
Ann Neurol. 64:628–634. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Barnholtz-Sloan JS, Maldonado JL, Williams
VL, Curry WT, Rodkey EA, Barker FG II and Sloan AE: Racial/ethnic
differences in survival among elderly patients with a primary
glioblastoma. J Neurooncol. 85:171–180. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Arrigo RT, Boakye M and Skirboll SL:
Patterns of care and survival for glioblastoma patients in the
Veterans population. J Neurooncol. 106:627–635. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Charlson ME, Pompei P, Ales KL and
MacKenzie CR: A new method of classifying prognostic comorbidity in
longitudinal studies: Development and validation. J Chronic Dis.
40:373–383. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Deyo RA, Cherkin DC and Ciol MA: Adapting
a clinical comorbidity index for use with ICD-9-CM administrative
databases. J Clin Epidemiol. 45:613–619. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zouaoui S, Darlix A, Fabbro-Peray P, et
al: Oncological patterns of care and outcomes for 265 elderly
patients with newly diagnosed glioblastoma in France. Neurosurg
Rev. 37:415–424. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Scott JG, Bauchet L, Fraum TJ, et al:
Recursive partitioning analysis of prognostic factors for
glioblastoma patients aged 70 years or older. Cancer.
118:5595–5600. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Darefsky AS, King JT Jr and Dubrow R:
Adult glioblastoma multiforme survival in the temozolomide era: A
population-based analysis of Surveillance, Epidemiology, and End
Results registries. Cancer. 118:2163–2172. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dubrow R, Darefsky AS, Jacobs DI, Park LS,
Rose MG, Laurans MS and King JT Jr: Time trends in glioblastoma
multiforme survival: The role of temozolomide. Neuro Oncol.
15:1750–1761. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yin AA, Zhang LH, Cheng JX, Dong Y, Liu
BL, Han N and Zhang X: Radiotherapy plus concurrent or sequential
temozolomide for glioblastoma in the elderly: A meta-analysis. PLoS
One. 8:e742422013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Roa W, Brasher PM, Bauman G, et al:
Abbreviated course of radiation therapy in older patients with
glioblastoma multiforme: A prospective randomized clinical trial. J
Clin Oncol. 22:1583–1588. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Noorbakhsh A, Tang JA, Marcus LP,
McCutcheon B, Gonda DD, Schallhorn CS, Talamini MA, Chang DC,
Carter BS and Chen CC: Gross-total resection outcomes in an elderly
population with glioblastoma: A SEER-based analysis. J Neurosurg.
120:31–39. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hegi ME, Diserens AC, Gorlia T, et al:
MGMT gene silencing and benefit from temozolomide in glioblastoma.
N Engl J Med. 352:997–1003. 2005. View Article : Google Scholar : PubMed/NCBI
|
